wrafton laboratories limited
wrafton laboratories limited Company Information
Company Number
02638733
Next Accounts
Sep 2025
Industry
Manufacture of basic pharmaceutical products
Shareholders
perrigo uk acquisition ltd
Group Structure
View All
Contact
Registered Address
wrafton, braunton, devon, EX33 2DL
Website
http://perrigo.comwrafton laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of WRAFTON LABORATORIES LIMITED at £203.9m based on a Turnover of £96.5m and 2.11x industry multiple (adjusted for size and gross margin).
wrafton laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of WRAFTON LABORATORIES LIMITED at £90.2m based on an EBITDA of £10.6m and a 8.52x industry multiple (adjusted for size and gross margin).
wrafton laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of WRAFTON LABORATORIES LIMITED at £106.3m based on Net Assets of £56.2m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Wrafton Laboratories Limited Overview
Wrafton Laboratories Limited is a live company located in devon, EX33 2DL with a Companies House number of 02638733. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in August 1991, it's largest shareholder is perrigo uk acquisition ltd with a 100% stake. Wrafton Laboratories Limited is a mature, large sized company, Pomanda has estimated its turnover at £96.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Wrafton Laboratories Limited Health Check
Pomanda's financial health check has awarded Wrafton Laboratories Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
3 Regular
2 Weak
Size
annual sales of £96.5m, make it larger than the average company (£37.1m)
£96.5m - Wrafton Laboratories Limited
£37.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (5.2%)
6% - Wrafton Laboratories Limited
5.2% - Industry AVG
Production
with a gross margin of 15.8%, this company has a higher cost of product (38.5%)
15.8% - Wrafton Laboratories Limited
38.5% - Industry AVG
Profitability
an operating margin of 7.8% make it as profitable than the average company (6.9%)
7.8% - Wrafton Laboratories Limited
6.9% - Industry AVG
Employees
with 589 employees, this is above the industry average (108)
589 - Wrafton Laboratories Limited
108 - Industry AVG
Pay Structure
on an average salary of £36.8k, the company has a lower pay structure (£67.7k)
£36.8k - Wrafton Laboratories Limited
£67.7k - Industry AVG
Efficiency
resulting in sales per employee of £163.8k, this is less efficient (£454k)
£163.8k - Wrafton Laboratories Limited
£454k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (56 days)
6 days - Wrafton Laboratories Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (34 days)
44 days - Wrafton Laboratories Limited
34 days - Industry AVG
Stock Days
it holds stock equivalent to 84 days, this is in line with average (103 days)
84 days - Wrafton Laboratories Limited
103 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 33 weeks, this is more cash available to meet short term requirements (10 weeks)
33 weeks - Wrafton Laboratories Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 29.2%, this is a lower level of debt than the average (44.6%)
29.2% - Wrafton Laboratories Limited
44.6% - Industry AVG
WRAFTON LABORATORIES LIMITED financials
Wrafton Laboratories Limited's latest turnover from December 2023 is £96.5 million and the company has net assets of £56.2 million. According to their latest financial statements, Wrafton Laboratories Limited has 589 employees and maintains cash reserves of £12.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 96,504,000 | 74,163,000 | 52,889,000 | 82,020,000 | 64,250,000 | 54,584,000 | 55,862,000 | 46,474,000 | 77,354,000 | 50,861,000 | 44,331,000 | 40,284,000 | 38,380,000 | 34,022,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 81,307,000 | 63,945,000 | 47,167,000 | 68,090,000 | 59,750,000 | 49,464,000 | 50,076,000 | 42,799,000 | 65,395,000 | 40,789,000 | 37,124,000 | 34,162,000 | 33,015,000 | 29,137,000 |
| Gross Profit | 15,197,000 | 10,218,000 | 5,722,000 | 13,930,000 | 4,500,000 | 5,120,000 | 5,786,000 | 3,675,000 | 11,959,000 | 10,072,000 | 7,207,000 | 6,122,000 | 5,365,000 | 4,885,000 |
| Admin Expenses | 7,678,000 | 6,709,000 | 4,325,000 | 6,829,000 | 6,881,000 | 6,956,000 | 6,841,000 | 6,840,000 | 9,616,000 | 5,184,000 | 4,537,000 | 4,507,000 | 5,181,000 | 5,175,000 |
| Operating Profit | 7,519,000 | 3,509,000 | 1,397,000 | 7,101,000 | -2,381,000 | -1,836,000 | -1,055,000 | -3,165,000 | 2,343,000 | 4,888,000 | 2,670,000 | 1,615,000 | 184,000 | -290,000 |
| Interest Payable | 391,000 | 82,000 | 17,000 | 58,000 | 48,000 | 25,000 | 16,000 | 139,000 | 291,000 | 187,000 | 182,000 | 239,000 | 110,000 | 42,000 |
| Interest Receivable | 639,000 | 13,000 | 0 | 3,000 | 9,000 | 29,000 | 0 | 0 | 4,000 | 2,000 | 0 | 2,000 | 2,000 | 1,000 |
| Pre-Tax Profit | 7,767,000 | 3,440,000 | 1,380,000 | 7,046,000 | -2,420,000 | -1,832,000 | -1,071,000 | -3,304,000 | 2,056,000 | 4,703,000 | 2,488,000 | 1,378,000 | 76,000 | -331,000 |
| Tax | -2,301,000 | -1,100,000 | -902,000 | -2,009,000 | 247,000 | 100,000 | 160,000 | 443,000 | -302,000 | -1,052,000 | -509,000 | -330,000 | -30,000 | 15,000 |
| Profit After Tax | 5,466,000 | 2,340,000 | 478,000 | 5,037,000 | -2,173,000 | -1,732,000 | -911,000 | -2,861,000 | 1,754,000 | 3,651,000 | 1,979,000 | 1,048,000 | 46,000 | -316,000 |
| Dividends Paid | 0 | 0 | 2,700,000 | 0 | 0 | 0 | 0 | 0 | 2,000,000 | 0 | 0 | 0 | 5,500,000 | 0 |
| Retained Profit | 5,466,000 | 2,340,000 | -2,222,000 | 5,037,000 | -2,173,000 | -1,732,000 | -911,000 | -2,861,000 | -246,000 | 3,651,000 | 1,979,000 | 1,048,000 | -5,454,000 | -316,000 |
| Employee Costs | 21,695,000 | 21,239,000 | 20,360,000 | 22,333,000 | 19,013,000 | 18,919,000 | 21,008,000 | 20,276,000 | 24,409,000 | 15,299,000 | 14,020,000 | 12,772,000 | 12,634,000 | 11,296,000 |
| Number Of Employees | 589 | 525 | 517 | 549 | 523 | 492 | 500 | 520 | 511 | 481 | 467 | 448 | 419 | 432 |
| EBITDA* | 10,585,000 | 6,205,000 | 4,021,000 | 9,620,000 | 174,000 | 1,019,000 | 1,480,000 | -604,000 | 4,780,000 | 6,415,000 | 4,222,000 | 3,423,000 | 2,248,000 | 1,475,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 30,525,000 | 30,921,000 | 30,319,000 | 29,186,000 | 24,288,000 | 23,637,000 | 22,647,000 | 17,105,000 | 14,702,000 | 10,396,000 | 10,364,000 | 9,962,000 | 10,190,000 | 11,009,000 |
| Intangible Assets | 244,000 | 244,000 | 244,000 | 245,000 | 249,000 | 252,000 | 395,000 | 403,000 | 439,000 | 173,000 | 97,000 | 136,000 | 180,000 | 199,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 30,769,000 | 31,165,000 | 30,563,000 | 29,431,000 | 24,537,000 | 23,889,000 | 23,042,000 | 17,508,000 | 15,141,000 | 10,569,000 | 10,461,000 | 10,098,000 | 10,370,000 | 11,208,000 |
| Stock & work in progress | 18,866,000 | 22,523,000 | 15,326,000 | 11,929,000 | 12,701,000 | 12,238,000 | 9,649,000 | 10,157,000 | 10,324,000 | 9,012,000 | 8,827,000 | 6,907,000 | 5,993,000 | 5,105,000 |
| Trade Debtors | 1,606,000 | 1,523,000 | 2,110,000 | 1,221,000 | 1,439,000 | 2,058,000 | 3,290,000 | 6,393,000 | 6,108,000 | 5,004,000 | 5,213,000 | 5,136,000 | 4,368,000 | 3,706,000 |
| Group Debtors | 13,992,000 | 10,595,000 | 11,105,000 | 15,645,000 | 7,890,000 | 4,321,000 | 7,375,000 | 671,000 | 556,000 | 2,928,000 | 546,000 | 279,000 | 325,000 | 133,000 |
| Misc Debtors | 1,706,000 | 1,447,000 | 1,088,000 | 2,646,000 | 2,205,000 | 1,633,000 | 1,812,000 | 1,217,000 | 489,000 | 331,000 | 226,000 | 247,000 | 361,000 | 385,000 |
| Cash | 12,458,000 | 8,892,000 | 7,847,000 | 0 | 0 | 0 | 0 | 0 | 0 | 3,224,000 | 1,004,000 | 262,000 | 642,000 | 1,062,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 48,628,000 | 44,980,000 | 37,476,000 | 31,441,000 | 24,235,000 | 20,250,000 | 22,126,000 | 18,438,000 | 17,477,000 | 20,499,000 | 15,816,000 | 12,831,000 | 11,689,000 | 10,391,000 |
| total assets | 79,397,000 | 76,145,000 | 68,039,000 | 60,872,000 | 48,772,000 | 44,139,000 | 45,168,000 | 35,946,000 | 32,618,000 | 31,068,000 | 26,277,000 | 22,929,000 | 22,059,000 | 21,599,000 |
| Bank overdraft | 0 | 0 | 0 | 22,900,000 | 22,417,000 | 17,528,000 | 14,968,000 | 8,772,000 | 1,938,000 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 9,896,000 | 11,600,000 | 8,908,000 | 9,334,000 | 7,459,000 | 6,816,000 | 6,207,000 | 5,726,000 | 6,306,000 | 4,984,000 | 5,926,000 | 4,875,000 | 3,814,000 | 2,455,000 |
| Group/Directors Accounts | 2,490,000 | 6,546,000 | 4,880,000 | 1,833,000 | 383,000 | 202,000 | 2,142,000 | 118,000 | 6,383,000 | 5,959,000 | 5,561,000 | 5,278,000 | 6,386,000 | 2,205,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31,000 | 131,000 | 151,000 | 42,000 | 111,000 | 115,000 | 96,000 |
| other current liabilities | 7,242,000 | 4,112,000 | 3,421,000 | 7,375,000 | 4,511,000 | 3,077,000 | 4,119,000 | 2,786,000 | 2,356,000 | 4,182,000 | 2,612,000 | 2,367,000 | 2,161,000 | 1,601,000 |
| total current liabilities | 19,628,000 | 22,258,000 | 17,209,000 | 41,442,000 | 34,770,000 | 27,623,000 | 27,436,000 | 17,433,000 | 17,114,000 | 15,276,000 | 14,141,000 | 12,631,000 | 12,476,000 | 6,357,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,000 | 35,000 | 204,000 | 43,000 | 46,000 | 111,000 | 166,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87,000 | 102,000 | 128,000 | 160,000 | 192,000 |
| other liabilities | 1,000 | 1,000 | 4,000 | 15,000 | 28,000 | 41,000 | 41,000 | 62,000 | 74,000 | 0 | 0 | 0 | 0 | 0 |
| provisions | 3,524,000 | 3,108,000 | 2,388,000 | 1,155,000 | 751,000 | 1,079,000 | 563,000 | 408,000 | 495,000 | 355,000 | 477,000 | 486,000 | 626,000 | 826,000 |
| total long term liabilities | 3,525,000 | 3,109,000 | 2,392,000 | 1,170,000 | 779,000 | 1,120,000 | 604,000 | 474,000 | 604,000 | 646,000 | 622,000 | 660,000 | 897,000 | 1,184,000 |
| total liabilities | 23,153,000 | 25,367,000 | 19,601,000 | 42,612,000 | 35,549,000 | 28,743,000 | 28,040,000 | 17,907,000 | 17,718,000 | 15,922,000 | 14,763,000 | 13,291,000 | 13,373,000 | 7,541,000 |
| net assets | 56,244,000 | 50,778,000 | 48,438,000 | 18,260,000 | 13,223,000 | 15,396,000 | 17,128,000 | 18,039,000 | 14,900,000 | 15,146,000 | 11,514,000 | 9,638,000 | 8,686,000 | 14,058,000 |
| total shareholders funds | 56,244,000 | 50,778,000 | 48,438,000 | 18,260,000 | 13,223,000 | 15,396,000 | 17,128,000 | 18,039,000 | 14,900,000 | 15,146,000 | 11,514,000 | 9,638,000 | 8,686,000 | 14,058,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 7,519,000 | 3,509,000 | 1,397,000 | 7,101,000 | -2,381,000 | -1,836,000 | -1,055,000 | -3,165,000 | 2,343,000 | 4,888,000 | 2,670,000 | 1,615,000 | 184,000 | -290,000 |
| Depreciation | 3,066,000 | 2,696,000 | 2,623,000 | 2,515,000 | 2,552,000 | 2,851,000 | 2,527,000 | 2,536,000 | 2,242,000 | 1,495,000 | 1,513,000 | 1,721,000 | 1,954,000 | 1,573,000 |
| Amortisation | 0 | 0 | 1,000 | 4,000 | 3,000 | 4,000 | 8,000 | 25,000 | 195,000 | 32,000 | 39,000 | 87,000 | 110,000 | 192,000 |
| Tax | -2,301,000 | -1,100,000 | -902,000 | -2,009,000 | 247,000 | 100,000 | 160,000 | 443,000 | -302,000 | -1,052,000 | -509,000 | -330,000 | -30,000 | 15,000 |
| Stock | -3,657,000 | 7,197,000 | 3,397,000 | -772,000 | 463,000 | 2,589,000 | -508,000 | -167,000 | 1,312,000 | 185,000 | 1,920,000 | 914,000 | 888,000 | 5,105,000 |
| Debtors | 3,739,000 | -738,000 | -5,209,000 | 7,978,000 | 3,522,000 | -4,465,000 | 4,196,000 | 1,128,000 | -1,110,000 | 2,278,000 | 323,000 | 608,000 | 830,000 | 4,224,000 |
| Creditors | -1,704,000 | 2,692,000 | -426,000 | 1,875,000 | 643,000 | 609,000 | 481,000 | -580,000 | 1,322,000 | -942,000 | 1,051,000 | 1,061,000 | 1,359,000 | 2,455,000 |
| Accruals and Deferred Income | 3,130,000 | 691,000 | -3,954,000 | 2,864,000 | 1,434,000 | -1,042,000 | 1,333,000 | 430,000 | -1,913,000 | 1,555,000 | 219,000 | 174,000 | 528,000 | 1,793,000 |
| Deferred Taxes & Provisions | 416,000 | 720,000 | 1,233,000 | 404,000 | -328,000 | 516,000 | 155,000 | -87,000 | 140,000 | -122,000 | -9,000 | -140,000 | -200,000 | 826,000 |
| Cash flow from operations | 10,044,000 | 2,749,000 | 1,784,000 | 5,548,000 | -1,815,000 | 3,078,000 | -79,000 | -1,359,000 | 3,825,000 | 3,391,000 | 2,731,000 | 2,666,000 | 2,187,000 | -2,765,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -4,056,000 | 1,666,000 | 3,047,000 | 1,450,000 | 181,000 | -1,940,000 | 2,024,000 | -6,265,000 | 424,000 | 398,000 | 283,000 | -1,108,000 | 4,181,000 | 2,205,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | -35,000 | -131,000 | -189,000 | 270,000 | -72,000 | -69,000 | -36,000 | 262,000 |
| other long term liabilities | 0 | -3,000 | -11,000 | -13,000 | -13,000 | 0 | -21,000 | -12,000 | 74,000 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 248,000 | -69,000 | -17,000 | -55,000 | -39,000 | 4,000 | -16,000 | -139,000 | -287,000 | -185,000 | -182,000 | -237,000 | -108,000 | -41,000 |
| cash flow from financing | -3,808,000 | 1,594,000 | 35,419,000 | 1,382,000 | 129,000 | -1,936,000 | 1,952,000 | -547,000 | 22,000 | 464,000 | -74,000 | -1,510,000 | 4,119,000 | 16,800,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 3,566,000 | 1,045,000 | 7,847,000 | 0 | 0 | 0 | 0 | 0 | -3,224,000 | 2,220,000 | 742,000 | -380,000 | -420,000 | 1,062,000 |
| overdraft | 0 | 0 | -22,900,000 | 483,000 | 4,889,000 | 2,560,000 | 6,196,000 | 6,834,000 | 1,938,000 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 3,566,000 | 1,045,000 | 30,747,000 | -483,000 | -4,889,000 | -2,560,000 | -6,196,000 | -6,834,000 | -5,162,000 | 2,220,000 | 742,000 | -380,000 | -420,000 | 1,062,000 |
wrafton laboratories limited Credit Report and Business Information
Wrafton Laboratories Limited Competitor Analysis
Perform a competitor analysis for wrafton laboratories limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in EX33 area or any other competitors across 12 key performance metrics.
wrafton laboratories limited Ownership
WRAFTON LABORATORIES LIMITED group structure
Wrafton Laboratories Limited has no subsidiary companies.
Ultimate parent company
PERRIGO INTERNATIONAL HOLDINGS INC
#0131676
2 parents
WRAFTON LABORATORIES LIMITED
02638733
wrafton laboratories limited directors
Wrafton Laboratories Limited currently has 3 directors. The longest serving directors include Mr Christopher Rudd (Apr 2018) and Mr Christopher Semple (Apr 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Rudd | 44 years | Apr 2018 | - | Director | |
| Mr Christopher Semple | 54 years | Apr 2024 | - | Director | |
| Mr Jason Ridge | 55 years | Apr 2024 | - | Director |
P&L
December 2023turnover
96.5m
+30%
operating profit
7.5m
+114%
gross margin
15.8%
+14.3%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
56.2m
+0.11%
total assets
79.4m
+0.04%
cash
12.5m
+0.4%
net assets
Total assets minus all liabilities
wrafton laboratories limited company details
company number
02638733
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
August 1991
age
33
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
ERNST & YOUNG LLP
address
wrafton, braunton, devon, EX33 2DL
Bank
-
Legal Advisor
-
wrafton laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to wrafton laboratories limited. Currently there are 1 open charges and 7 have been satisfied in the past.
wrafton laboratories limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WRAFTON LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.
wrafton laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
